Newbury Pharmaceuticals Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Newbury Pharmaceuticals
Access all reports
Newbury Pharmaceuticals AB is a Sweden-based company specializing in specialty prescription drugs. The company's portfolio includes products across therapeutic areas such as oncology, rare diseases, and neurology. Newbury Pharmaceuticals primarily serves the Scandinavian market, focusing on developing both proprietary and licensed pharmaceutical products. The company is headquartered in Lund, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
NEWBRY
Country
🇸🇪 Sweden